Method for prevention of pseudomonas aeruginosa infections

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3902

Patent

active

039871649

ABSTRACT:
The invention involves vaccine preparations comprising cell wall protein component of Pseudomonas aeruginosa as active ingredient and a pharmaceutically acceptable carrier. The preparations are suitable for parenteral administration for prophylactic treatment of disease caused by infection of Pseudomonas aeruginosa. The cell wall protein component is characterized by the fact that the same exhibits low toxicity and without type-specificity to the variety of antigens of Pseudomonas aeruginosa.

REFERENCES:
homma et al. - J. Bacteriology - vol. 87, (Mar. 1964) pp. 630-640.
Homma et al. - Annals of the N.Y. Academy of Sciences, vol. 133 pp. 508-526 (1966).
Alexander et al. - Surgery Gynecology & Obstetrics - vol. 123 No. 5 (Nov. 1966) pp. 965 to 977.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for prevention of pseudomonas aeruginosa infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for prevention of pseudomonas aeruginosa infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prevention of pseudomonas aeruginosa infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-102854

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.